John O. Richards

1.8k total citations
32 papers, 1.4k citations indexed

About

John O. Richards is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John O. Richards has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in John O. Richards's work include Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). John O. Richards is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). John O. Richards collaborates with scholars based in United States, Germany and South Africa. John O. Richards's co-authors include Sher Karki, John R. Desjarlais, S. Nandi, Laura Beretta, Samir Hanash, Hsing Chen, Wei Dang, Greg A. Lazar, Betsy Barnes and Paula M. Pitha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

John O. Richards

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John O. Richards United States 16 638 477 423 370 121 32 1.4k
Stefan Wirths Germany 17 1.2k 1.9× 575 1.2× 601 1.4× 217 0.6× 77 0.6× 55 1.6k
Eric Braakman Netherlands 24 801 1.3× 421 0.9× 279 0.7× 174 0.5× 114 0.9× 63 1.3k
Michele Mondini France 25 818 1.3× 594 1.2× 598 1.4× 201 0.5× 358 3.0× 64 1.8k
H. Bernhard Germany 19 876 1.4× 669 1.4× 459 1.1× 255 0.7× 141 1.2× 35 1.5k
Loren D. Erickson United States 26 1.7k 2.7× 472 1.0× 514 1.2× 327 0.9× 143 1.2× 41 2.5k
T K Kishimoto United States 18 1.3k 2.1× 272 0.6× 656 1.6× 317 0.9× 113 0.9× 23 2.4k
Paulo Vidal Campregher Brazil 12 950 1.5× 569 1.2× 323 0.8× 133 0.4× 140 1.2× 57 1.7k
Ludger Große‐Hovest Germany 19 712 1.1× 655 1.4× 282 0.7× 281 0.8× 79 0.7× 46 1.2k
Claudia Bossen United States 14 1.4k 2.1× 272 0.6× 924 2.2× 266 0.7× 102 0.8× 20 2.2k
Rony Dahan Israel 19 1.4k 2.2× 771 1.6× 618 1.5× 587 1.6× 110 0.9× 26 2.1k

Countries citing papers authored by John O. Richards

Since Specialization
Citations

This map shows the geographic impact of John O. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John O. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John O. Richards more than expected).

Fields of papers citing papers by John O. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John O. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John O. Richards. The network helps show where John O. Richards may publish in the future.

Co-authorship network of co-authors of John O. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of John O. Richards. A scholar is included among the top collaborators of John O. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John O. Richards. John O. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tjoe, Judy A., Linda B. Piacentine, Paula E. Papanek, et al.. (2020). Team triathlon effects on physiological, psychological, and immunological measures in women breast cancer survivors. Supportive Care in Cancer. 28(12). 6095–6104. 8 indexed citations
2.
3.
Yin, Jun‐Jie, et al.. (2018). Differential regulation of human monocytes and NK cells by antibody-opsonized tumors. Cancer Immunology Immunotherapy. 67(8). 1239–1250. 7 indexed citations
4.
Singh, Maharaj, et al.. (2017). Multiple Myeloma Vaccination Patterns in a Large Health System: A Pilot Study. SHILAP Revista de lepidopterología. 4(2). 53–59. 6 indexed citations
5.
Richards, John O., et al.. (2016). Vaccination in Multiple Myeloma: Review of Current Literature. Clinical Lymphoma Myeloma & Leukemia. 16(9). 495–502. 18 indexed citations
6.
Richards, John O., et al.. (2016). NK cell-mediated antibody-dependent cellular cytotoxicity is enhanced by tamoxifen in HER2/neu non-amplified, but not HER2/neu-amplified, breast cancer cells. Cancer Immunology Immunotherapy. 65(11). 1325–1335. 11 indexed citations
7.
Rizvi, Farhan, Larisa Emelyanova, Gracious R. Ross, et al.. (2015). TGF-β1-Mediated Differentiation of Fibroblasts Is Associated with Increased Mitochondrial Content and Cellular Respiration. PLoS ONE. 10(4). e0123046–e0123046. 72 indexed citations
8.
Richards, John O., et al.. (2012). Flow cytometry assessment of residual melanoma cells in tumor‐infiltrating lymphocyte cultures. Cytometry Part A. 81A(5). 374–381. 12 indexed citations
9.
Horton, Holly M., Matthew J. Bernett, Erik Pong, et al.. (2008). Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia. Cancer Research. 68(19). 8049–8057. 187 indexed citations
10.
Richards, John O., Sher Karki, Greg A. Lazar, et al.. (2008). Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells. Molecular Cancer Therapeutics. 7(8). 2517–2527. 235 indexed citations
11.
Charlton, R., Matthew Henderson, John O. Richards, et al.. (2008). G.P.14.01 Immunohistochemical analysis of calpain 3: Advantages and limitations in diagnosing LGMD2A. Neuromuscular Disorders. 18(9-10). 815–815. 1 indexed citations
12.
13.
Richards, John O., Beth A. McNally, Xianfeng Fang, et al.. (2008). Tumor Growth Decreases NK and B Cells as well as Common Lymphoid Progenitor. PLoS ONE. 3(9). e3180–e3180. 19 indexed citations
14.
Richards, John O., et al.. (2007). The risk of sympathetic ophthalmia following evisceration for penetrating eye injuries at Groote Schuur Hospital. British Journal of Ophthalmology. 92(1). 61–63. 43 indexed citations
15.
Richards, John O., Xing Chang, Bradley W. Blaser, et al.. (2006). Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood. 108(1). 246–252. 77 indexed citations
16.
Barnes, Betsy, et al.. (2004). Global and Distinct Targets of IRF-5 and IRF-7 during Innate Response to Viral Infection. Journal of Biological Chemistry. 279(43). 45194–45207. 188 indexed citations
17.
Richards, John O., Neil M. Ampel, & Douglas F. Lake. (2002). Reversal of Coccidioidal Anergy In Vitro by Dendritic Cells from Patients with Disseminated Coccidioidomycosis. The Journal of Immunology. 169(4). 2020–2025. 28 indexed citations
18.
Richards, John O., François Le Naour, Samir Hanash, & Laura Beretta. (2002). Integrated Genomic and Proteomic Analysis of Signaling Pathways in Dendritic Cell Differentiation and Maturation. Annals of the New York Academy of Sciences. 975(1). 91–100. 55 indexed citations
19.
Richards, John O., Neil M. Ampel, John N. Galgiani, & Douglas F. Lake. (2001). Dendritic Cells Pulsed withCoccidioides immitisLysate Induce Antigen‐Specific Naive T Cell Activation. The Journal of Infectious Diseases. 184(9). 1220–1224. 27 indexed citations
20.
Edery, Marc, Michael McGrath, John O. Richards, Pierre Martin, & Shyam Sundar Nandi. (1983). 180 Maintenance of estrogen and progesterone receptors in normal and tumor mammary cells grown in collagen gel matrix culture. Journal of Steroid Biochemistry. 19. 60–60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Wirths Breakdown of academic impact, for papers by Eric Braakman Breakdown of academic impact, for papers by Michele Mondini Breakdown of academic impact, for papers by H. Bernhard Breakdown of academic impact, for papers by Loren D. Erickson Breakdown of academic impact, for papers by T K Kishimoto Breakdown of academic impact, for papers by Paulo Vidal Campregher Breakdown of academic impact, for papers by Ludger Große‐Hovest Breakdown of academic impact, for papers by Claudia Bossen Breakdown of academic impact, for papers by Rony Dahan
Rankless by CCL
2026